Navigation Links
Eisai Launches New Website Providing Employers with Educational Resource for Obesity Management
Date:8/15/2013

WOODCLIFF LAKE, N.J., Aug. 15, 2013 /PRNewswire/ -- Eisai Inc. announced today the launch of a new website to provide employers with an educational resource for information about obesity management. The website, "Closing the Gap: Obesity Management for Employers," can be accessed at http://ctgobesity.com/.

"We know from our research that most employers consider obesity to be a top employee health challenge," said Dave Martin, Vice President of Managed Markets, Value and Access for Eisai.  "While there are some helpful resources available for employers, we also noted significant gaps; therefore, we decided to build this all-inclusive website as a companion to an e-newsletter, in partnership with The Benfield Group."

Both the e-newsletter and the website will provide employers access to articles, links to other sites and other downloadable tools including:Closing the Gap in Obesity Management Solutions: The Importance of Integrating New Prescription Medications into Employer Strategies to Help Reduce Obesity in their Employee and Dependent Populations. A publication that reviews the challenges and opportunities of obesity management and provides recommendations from an Eisai-sponsored advisory board of leading employer health benefit decision-makers on approaches to update employer strategies.

Blueprint for Health™: A free, interactive online tool available through the American College of Occupational and Environmental Medicine (ACOEM) that allows employers to estimate direct and indirect costs associated with the conditions they select, by entering key employee demographics.

Your Weight Matters(SM) Campaign (YWM): The Your Weight Matters Campaign was developed by the Obesity Action Coalition (OAC) and sponsored by Eisai. The Your Weight Matters Campaign encourages all Americans to measure their weight and take the Campaign Challenge by making a pledge to talk to a healthcare provider about their weight and its impact on their health. All Campaign participants receive a FREE toolkit to help them prepare for the conversation of weight with their healthcare provider.

The content for the Blueprint for Health and Your Weight Matters Campaign websites are not controlled by Eisai.

Eisai Inc.At Eisai Inc., human health care is our goal. We give our first thoughts to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to help address unmet medical needs. We are a fully integrated pharmaceutical business with discovery, clinical, manufacturing and marketing capabilities. Our key areas of commercial focus include oncology and specialty care (Alzheimer's disease, epilepsy and metabolic disorders). To learn more about Eisai Inc., please visit us at www.eisai.com/US

Eisai Inc. has affiliates that are part of a global product creation organization that includes R&D facilities in Massachusetts, New Jersey, North Carolina and Pennsylvania, as well as a global demand chain organization that includes manufacturing facilities in Maryland and North Carolina. Eisai's global areas of R&D focus include neuroscience; oncology; metabolic disorders; vascular, inflammatory and immunological reaction; and antibody-based programs. Media Inquiries  Investor InquiriesMarcia Diljak

Alex ScottEisai Inc.

Eisai Inc.(201) 746-2236 

(201) 746-2177


'/>"/>
SOURCE Eisai Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. FDA Grants Orphan Drug Status To Eisais Investigational Compound (E7777) For Cutaneous T-Cell Lymphoma
2. For Treating Psoriatic Arthritis, Clinical Data and Thought Leaders Opinions Indicate that AbbVie/Eisais Humira Has the Best Clinical Profile Among Key Marketed Therapies
3. Eisai USA Foundation to Donate $1 Million to the Conquer Cancer Foundation of the American Society of Clinical Oncology
4. Eisai To Sponsor 7th Annual National Walk For Epilepsy To Help Raise Epilepsy Awareness
5. Lynn Kramer, MD, Appointed Chief Clinical Officer of Eisai Product Creation Systems
6. FDA Grants Orphan Drug Status To Eisais Lenvatinib
7. Eisai Oncology to Present New Research on Eribulin at 35th Annual San Antonio Breast Cancer Symposium
8. Eisai USA Foundation to Donate $100,000 to the Hurricane Sandy New Jersey Relief Fund, $50,000 to the American Red Cross
9. Epilepsia Publishes Results From Two Studies Of Eisais Perampanel
10. Shaji Procida Appointed Vice President and Chief Financial Officer of Eisai Inc.
11. Eisai Oncology to Present New Research on Product Portfolio and Pipeline at ASCO Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... SHANGHAI , Jan. 18, 2017 In ... of revolution, which is where the Upgrade of ... year of the 13th Five-Year Plan for Economic and Social ... (the 13th Five-Year Plan), and the state council of ... the "13th Five-Year" national strategic emerging industry development plan, identifying ...
(Date:1/18/2017)... Invetech, the leading developer of ... , has announced a collaboration agreement with Erytech ... treatments for acute leukemia and other oncology indications ... will develop systems to enable the commercial-scale manufacture ... platform, which uses a novel technology to encapsulate ...
(Date:1/18/2017)... , Jan. 18, 2017  Tarix Orphan LLC today ... granted a Rare Pediatric Disease (RPD) designation for the ... Dystrophic Epidermolysis Bullosa (RDEB), a rare genetic skin disorder. ... treatment is limited to supportive care. "The ... Drug Designation previously granted by the FDA in this ...
Breaking Medicine Technology:
(Date:1/18/2017)... KS (PRWEB) , ... January 18, 2017 , ... ... firm offering asset protection and financial planning services to families and business owners ... charity event aimed at supporting children with developmental disabilities. , The Lakemary Center ...
(Date:1/18/2017)... ... January 18, 2017 , ... Catalent Pharma Solutions, the leading ... consumer health products, today announced that Mr. Michael Merges, Director of Strategic Growth, ... be held at the Mayflower Hotel, Washington DC, on Jan. 24 – 26, ...
(Date:1/18/2017)... Lebanon, NH (PRWEB) , ... January 18, 2017 ... ... the launch of the revolutionary Active Brake Technology (ABT), an innovative braking system ... stability. , Active Brake Technology addresses one of the biggest concerns of beginner ...
(Date:1/17/2017)... ... ... January is National Stalking Awareness Month (NSAM), now in its fourteenth year, when ... the crime of stalking, a very real danger to many in our community. We ... and other crimes. , “Stalking: know it. Name it. Stop it.”—so reads the theme for ...
(Date:1/17/2017)... , ... January 17, 2017 , ... ... point of difference. Eden Activewear is a stand-out company for several differences from ... online and only manufacture on demand, this is called 'Agile' manufacturing - ...
Breaking Medicine News(10 mins):